APOE Antibodies
Apolipoprotein E (APOE) is a glycoprotein that is involved in the regulation of lipid metabolism. In the central nervous system, it is found in astrocytes, microglia, blood vessel wall cells, and choroid plexus cells. APOE is polymorphic and contains three allelic mutants: APOE*ε2, APOE*ε3, and APOE*ε4.
APOE Overview
Research indicates that APOE is a significant risk factor for late-onset Alzheimer's disease (AD). APOE*ε2 protects against AD, while APOE*ε4 raises the risk. The number of APOE genotypes carried also influences the likelihood of acquiring AD. The risk of AD increases 3-4 times in individuals carrying one APOE*ε4, but increases 9–15 times in those carrying two. APOE modulates the expression of brain β-amyl plaques, tau protein, and TDP43 protein in AD patients, as well as normal brain function.
Fig.1 Structural model of apoE1,2.
The Influence of APOE on AD Pathogenesis
- (Amyloid Beta) Aβ metabolism: APOE plays a role in the formation of β-amyloid plaques in the brain by regulating amyloid protein production, clearance, and deposition near neurons. Research indicates that APOE*ε4 can significantly increase the production and accumulation of Aβ in neurons.
- Neuroinflammation: APOE can affect inflammation in the brain, and the APOE ε4 allele may promote the development of AD by modulating the inflammatory response of microglia.
- Cerebrovascular: APOE impairs the integrity and function of cerebral blood vessels. The APOE ε4 allele may damage cerebral blood vessels and accelerate the onset of AD.
- Synaptic function: The APOE ε4 allele may modify synaptic signaling and plasticity, leading to AD pathogenesis.
APOE Antibodies Selection Guide
Creative Biolabs' APOE antibodies offer constant and accurate experimental results in APOE-related research fields due to their precise and dependable immune response effects. Whether you are looking for an APOE marker or examining APOE function in vitro, in cells, or in animal models, our APOE antibodies are the perfect tool for investigating. If you'd like to learn more about APOE-related antibodies, please click on the form below or contact us directly, and we'll get back to you as soon as possible.
Target | Cat. No | Product Name | Host | Application |
Total ApoE | NRZP-0922-ZP1575 | Anti-ApoE (CBP12886) | Rabbit | WB; IP; IHC; IF |
NRZP-0922-ZP1570 | Anti-ApoE (CBP12881) | Rabbit | WB; IP; IHC; IF | |
NRZP-0922-ZP1571 | Anti-ApoE (CBP12882) | Rabbit | WB; IHC; IF | |
NRZP-0922-ZP1572 | Anti-ApoE (CBP12883) | Mouse | WB; IHC; IF | |
NAB-0321-R0594 | Mouse Anti-APOE Monoclonal Antibody (CBP5263) | Mouse | IHC; WB | |
NAB-1021-R0399 | Rabbit Anti-APOE Monoclonal Antibody (CBP6530) | Rabbit | IP; ICC; IF; IHC; WB | |
NAB2010249LS | Rat Anti-Mouse Apolipoprotein E Monoclonal Antibody (CBP2304) | Rat | FC | |
ApoE4 | NAB201235LS | Anti-Apo E4 Monoclonal Antibody (CBP3696) | Mouse | ELISA |
NRZP-0922-ZP1573 | Anti-ApoE4 Antibody (CBP12884) | Rabbit | WB; IHC | |
NRZP-0922-ZP1574 | Anti-ApoE4 Antibody (CBP12885) | Mouse | WB | |
ApoE3 | NRZP-1022-ZP3639 | Anti-ApoE3 ApoE4 BBB Shuttle Antibody | Mouse | WB; ELISA; In Vitro |
NRZP-1022-ZP3503 | Anti-ApoC3 BBB Shuttle Antibody | Human | WB; ELISA; Inhib; In Vitro; In Vivo; Antagonist |
References
- Raulin, Ana-Caroline, et al. "ApoE in Alzheimer' s disease: pathophysiology and therapeutic strategies." Molecular neurodegeneration 17.1 (2022): 72.
- Image retrieved from Figure 1 "Structural model of apoE highlighting AD-related amino acid variations." Raulin et al., 2022, used under [CC BY 4.0]. The title was changed to "Structural model of apoE."
- NeuroMab™ Anti-Tau Antibody(NRP-0422-P1760) (Cat#: NRP-0422-P1760)
- NeuroMab™ Anti-Tau Antibody(NRP-0422-P1684) (Cat#: NRP-0422-P1684)
- NeuroMab™ Anti-Alpha Synuclein Antibody(NRP-0422-P614) (Cat#: NRP-0422-P614)
- NeuroMab™ Anti-SEZ6 Antibody(NRP-0422-P517) (Cat#: NRP-0422-P517)
- NeuroMab™ Anti-SEZ6 Antibody(NRP-0422-P515) (Cat#: NRP-0422-P515)
- NeuroMab™ Anti-Tau Antibody(NRP-0422-P1683) (Cat#: NRP-0422-P1683)
- NeuroMab™ Rabbit Anti-LRRK2 Monoclonal Antibody (CBP1887) (Cat#: NAB-08-PZ735)
- NeuroMab™ Anti-Amyloid Beta 1-15 Antibody(NRP-0422-P867) (Cat#: NRP-0422-P867)
- Mouse Anti-Human α-Synuclein Phospho (Tyr39) (CBP3706) (Cat#: NAB201250LS)
- NeuroMab™ Mouse Anti-SHANK3 Monoclonal Antibody (CBP929) (Cat#: NAB-0720-Z3477)
- Rat Retinal Muller Cell Line, Immortalized (Cat#: NCL-21P6-192)
- Human Brain Astroblastoma U-87 MG (Cat#: NCL2110P117)
- Mouse Microglia N9 (Cat#: NCL2110P073)
- Human Astrocytes (Cat#: NCC20-9PZ01)
- Human Blood Brain Barrier Model (Cat#: NCL-2103-P187)
- Rat Glioma Cell Line C6 (Cat#: NCL2110P346)
- Mouse Glioma Cell Line GL261 (Cat#: NCL-2108P28)
- Immortalized Human Cerebral Microvascular Endothelial Cells (Cat#: NCL-2108-P020)
- Rat Immortalized Retinal Muller Cell Line rMC-1 (Cat#: NCL-2106-S93)
- iNeu™ Human Oligodendrocyte Progenitor Cells (OPCs) (Cat#: NCL-2103-P49)
- Human GFAP ELISA Kit [Colorimetric] (Cat#: NPP2011ZP383)
- Human Poly ADP ribose polymerase,PARP Assay Kit (Cat#: NRZP-1122-ZP62)
- Human Tau Aggregation Kit (Cat#: NRP-0322-P2173)
- Alpha-Synuclein Aggregation Assay Kit (Cat#: NRZP-1122-ZP37)
- Alpha Synuclein Aggregation Kit (Cat#: NRZP-1122-ZP15)
- Beta Amyloid (1-40), Aggregation Kit (Cat#: NRZP-0323-ZP199)
- Beta Amyloid (1-42), Aggregation Kit (Cat#: NRZP-0323-ZP200)
- Amyloid beta 1-42 Kit (Cat#: NRP-0322-P2170)
- Dextran-CYanine5.5 (Cat#: NTA-2011-ZP118)
- AAV2/9-hEF1a-fDIO-eNpHR 3.0-mCherry-WPRE-pA (Cat#: NTA-2012-ZP78)
- pAAV-EF1a-DIO-EGFP-WPRE (Cat#: NTA-2012AD-P285)
- rAAV-CAG-DIO-G-Flamp1 (Cat#: NRZP-0722-ZP719)
- pAAV-hSyn-DIO-XCaMP-R-WPRE (Cat#: NTA-2012AD-P508)
- AAV2/2Retro-CAG-DIO-EGFP-2A-TetTox-pA [Neural Tracing] (Cat#: NTA-2012-ZP303)
- AAV2 Full Capsids, Reference Standards (Cat#: NTC2101070CR)
- Dextran-FITC (Cat#: NTA-2011-ZP110)
- PRV-CAG-EGFP (Cat#: NTA-2011-ZP14)
- AAV-mDLX-CRE-tdTomato (Cat#: NRZP-0622-ZP721)
- Rat Parkinson disease (autosomal recessive, juvenile) 2, parkin (Park2) (NM_020093) ORF clone/lentiviral particle, Myc-DDK Tagged (Cat#: NEP-0621-R0041)
- Human huntingtin-associated protein 1 (HAP1) transcript variant 2 (NM_177977) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0676)
- Human superoxide dismutase 1, soluble (SOD1) (NM_000454) ORF clone, TurboGFP Tagged (Cat#: NEP-0521-R0748)
- Lenti of Mouse synuclein, alpha (Snca) transcript variant (NM_001042451) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0864)
- Mouse SOD1 shRNA Silencing Adenovirus (Cat#: NV-2106-P14)
- App Rat amyloid beta (A4) precursor protein (App)(NM_019288) ORF clone, Untagged (Cat#: NEP-0421-R0053)
- Human huntingtin (HTT) (NM_002111) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0497)
- Mouse Parkinson disease (autosomal recessive, early onset) 7 (Park7) (NM_020569) clone, Untagged (Cat#: NEP-0621-R0133)
- ABCA1 Antisense Oligonucleotide (NV-2106-P27) (Cat#: NV-2106-P27)
- Human superoxide dismutase 3, extracellular (SOD3) (NM_003102) ORF clone, Untagged (Cat#: NEP-0521-R0808)
- NeuroBiologics™ Pig Cerebrospinal Fluid (Cat#: NRZP-0822-ZP498)
- NeuroBiologics™ Rat Cerebrospinal Fluid (Cat#: NRZP-0822-ZP496)
- NeuroBiologics™ Human Cerebrospinal Fluid (Cat#: NRZP-0822-ZP491)
- NeuroBiologics™ Mouse Cerebrospinal Fluid (Cat#: NRZP-0822-ZP497)
- NeuroBiologics™ Monkey Cerebrospinal Fluid (Cat#: NRZP-0822-ZP495)
- NeuroPro™ Anti-idursulfase BBB Shuttle Protein (Cat#: NRZP-0423-ZP497)
- NeuroPro™ Anti-EPO BBB Shuttle Protein (Cat#: NRZP-0423-ZP508)
- NeuroPro™ Anti-SGSH BBB Shuttle Protein (Cat#: NRZP-0423-ZP505)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP502)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP501)
- NeuroPro™ Anti-Erythropoietin BBB Shuttle Protein (Cat#: NRZP-0423-ZP499)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP510)
- NeuroPro™ Anti-GDNF BBB Shuttle Protein (Cat#: NRZP-0423-ZP509)
- NeuroPro™ Anti-ASA BBB Shuttle Protein (Cat#: NRZP-0423-ZP504)
- NeuroPro™ Anti-IDS BBB Shuttle Protein (Cat#: NRZP-0423-ZP503)